
Sign up to save your podcasts
Or


Though currently littered with penny stocks, the landscape for investing in marijuana is improving. Shannon Jones analyzes the recent merger of Aurora Cannabis and MedReleaf, and the impending FDA approval for GW Pharmaceuticals. Plus, we discuss how professional athletes and owners are helping the case by becoming more vocal about marijuana as a device for pain management.
By The Motley Fool4.7
16041,604 ratings
Though currently littered with penny stocks, the landscape for investing in marijuana is improving. Shannon Jones analyzes the recent merger of Aurora Cannabis and MedReleaf, and the impending FDA approval for GW Pharmaceuticals. Plus, we discuss how professional athletes and owners are helping the case by becoming more vocal about marijuana as a device for pain management.

3,217 Listeners

1,482 Listeners

808 Listeners

944 Listeners

521 Listeners

1,170 Listeners

2,201 Listeners

825 Listeners

1,422 Listeners

1,038 Listeners

9,715 Listeners

195 Listeners

833 Listeners

84 Listeners

584 Listeners

1,049 Listeners

56 Listeners